Search
for

    Glossary Cannabinoid Receptor Type 2

    protein involved in immune response and inflammation regulation

    Cannabinoid Receptor Type 2 (CB2 receptor) is a protein found primarily in the immune system and peripheral tissues. It plays a crucial role in modulating inflammation and immune responses. Unlike its counterpart, the CB1 receptor, which is mainly located in the brain and central nervous system, CB2 receptors are less associated with psychoactive effects and are being studied for their potential therapeutic benefits in conditions like chronic pain, autoimmune diseases, and even hair growth disorders.

    Related Terms

    Research 10 of 300

    1. 438 Laminin-511 is a new player in the development of psoriasis and controlled via cannabinoid receptor type 1 2016
    2. 1370 17β-estradiol may control human HF growth also via up-regulating the expression of cannabinoid receptor type1 expression 2018
    3. 1348 Involvement of mast cells and CB1 in the pathogenesis of IgA vasculitis Journal of Investigative Dermatology · 2023
    4. Peer Review #2 of "A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ (v0.1)" 2013
    5. Topical and nutricosmetic products for healthy hair and dermal antiaging using “dual‐acting” (2 for 1) plant‐based peptides, hormones, and cannabinoids FASEB bioAdvances · 2021 · 13 citations
    6. Cannabinoids and Their Receptors in Skin Diseases International journal of molecular sciences · 2023 · 1 citations
    7. Human epithelial stem cell survival within their niche requires “tonic” cannabinoid receptor 1‐signalling—Lessons from the hair follicle Experimental Dermatology · 2021 · 14 citations
    8. Stem Cells and their Niches Journal of Investigative Dermatology · 2013 · 1 citations
    9. Peer Review #1 of "A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ (v0.1)" 2013
    10. A Summary of Pre-Clinical and Clinical Evidence for Cannabinoid Hair Follicle Effects Clinical dermatology open access journal · 2022
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →